Efficacy of venlafaxine compared with tricyclic antidepressants in depressive disorder: A meta-analysis

Journal of Psychopharmacology

Volumn 23, Issue 6, 2009, Pages 708-713

  Van Den Broek, W W ^a   Mulder, P G H ^a   Van Os, E ^a   Birkenhager T K ^a   Pluijms, E ^a   Bruijn, J A ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Amitryptiline; Clomipramine; Depression; Imipramine; Tricyclic antidepressants; Venlafaxine

Indexed keywords

AMITRIPTYLINE; CLOMIPRAMINE; DESIPRAMINE; IMIPRAMINE; NORTRIPTYLINE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DEPRESSION; DOSE RESPONSE; DRUG EFFICACY; DRUG FATALITY; DRUG OVERDOSE; DRUG SURVEILLANCE PROGRAM; DRUG TOLERABILITY; DRUG WITHDRAWAL; HAMILTON SCALE; HUMAN; LOW DRUG DOSE; META ANALYSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; SUICIDE; SYSTEMATIC REVIEW; TREATMENT OUTCOME; TREATMENT PLANNING; UNSPECIFIED SIDE EFFECT;

ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; ANTIDEPRESSIVE AGENTS, TRICYCLIC; CYCLOHEXANOLS; DEPRESSIVE DISORDER; HUMANS; ODDS RATIO; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN; TREATMENT OUTCOME;

EID: 67651163696     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881108089821     Document Type: Review

References (34)

1. Abdelmawla AH Langley RW Szabadi E Bradshaw CM (1999) Comparison of the effects of venlafaxine, desipramine, and paroxetine on noradrenaline- and methoxamine-evoked constriction of the dorsal hand vein. Br J Clin Pharmacol 48: 345-354.
2. Anderson IM (1998) SSRIS versus tricyclic antidepressants in depressed inpatients: a meta-analysis of efficacy and tolerability. Depress Anxiety 7 (Suppl. 1). 11-17.
3. Anderson IM (2000) Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability. J Affect Disord 58: 19-36.
4. Benkert O Grunder G Wetzel H Hackett D (1996) A randomized, double-blind comparison of a rapidly escalating dose of venlafaxine and imipramine in inpatients with major depression and melancholia. J Psychiatr Res 30: 441-451.
5. Birkenhager TK van den Broek WW Moleman P Vulto AG Bruijn JA (2005) Imipramine dose in relation to therapeutic plasma level: are clinical trials using imipramine as a positive control flawed? Psychopharmacology (Berl) 181: 595-599.
6. Bruijn JA Moleman P Mulder PG van den Broek WW (1999) Depressed in-patients respond differently to imipramine and mirtazapine. Pharmacopsychiatry 32: 87-92.
7. Deshauer D (2007) Venlafaxine (Effexor). concerns about increased risk of fatal outcomes in overdose. Can Med Assoc J 176: 39-40.
8. DUAG (1986) Citalopram: clinical effect profile in comparison with clomipramine. A controlled multicenter study. Danish University Antidepressant Group. Psychopharmacology (Berl) 90: 131-138.
9. DUAG (1990) Paroxetine: a selective serotonin reuptake inhibitor showing better tolerance, but weaker antidepressant effect than clomipramine in a controlled multicenter study. Danish University Antidepressant Group. J Affect Disord 18: 289-299.
10. Freemantle N Anderson IM Young P (2000) Predictive value of pharmacological activity for the relative efficacy of antidepressant drugs. Meta-regression analysis. Br J Psychiatry 177: 292-302.
11. Gasto C Navarro V Marcos T Portella MJ Torra M Rodamilans M (2003) Single-blind comparison of venlafaxine and nortriptyline in elderly major depression. J Clin Psychopharmacol 23: 21-26.
12. Gentil V Kerr-Correa F Moreno R D'Arrigo Busnello E de Campo JA Juruena MF (2000) Double-blind comparison of venlafaxine and amitryptiline in outpatients with major depression with or without melancholia. J Psychopharmacol 14: 61-66.
13. Glassman AH Perel JM Shostak M Kantor SJ Fleiss JL (1977) Clinical implications of imipramine plasma levels for depressive illness. Arch Gen Psychiatry 34: 197-204.
14. Harvey AT Rudolph RL Preskorn SH (2000) Evidence of the dual mechanisms of action of venlafaxine. Arch Gen Psychiatry 57: 503-509.
15. Heninger GR Delgado PL Charney DS (1996) The revised monoamine theory of depression: a modulatory role for monoamines, based on new findings from monoamine depletion experiments in humans. Pharmacopsychiatry 29: 2-11.
16. Holliday SM Benfield P (1995) Venlafaxine. A review of its pharmacology and therapeutic potential in depression. Drugs 49: 280-294.
17. Lecrubier Y Bourin M Moon CA Schifano F Blanchard C Danjou P (1997) Efficacy of venlafaxine in depressive illness in general practice. Acta Psychiatr Scand 95: 485-493.
18. Nelson JC Mazure CM Bowers MB Jatlow PI (1991) A preliminary, open study of the combination of fluoxetine and desipramine for rapid treatment of major depression. Arch Gen Psychiatry 48: 303-307.
19. Preskorn SH; (1994) Antidepressant drug selection: criteria and options. J Clin Psychiatry 55(Suppl. A): 6-22, discussion 23-24, 98-100.
20. Samuelian JC Hackett D (1998) A randomized, double-blind, parallel-group comparison of venlafaxine and clomipramine in outpatients with major depression. J Psychopharmacol 12: 273-278.
21. Sauer H Huppertz-Helmhold S Dierkes W (2003) Efficacy and safety of venlafaxine ER vs. amitriptyline ER in patients with major depression of moderate severity. Pharmacopsychiatry 36: 169-175.
22. Schweizer E Feighner J Mandos LA Rickels K (1994) Comparison of venlafaxine and imipramine in the acute treatment of major depression in outpatients. J Clin Psychiatry 55: 104-108. (Pubitemid 24116436)
23. Seth R Jennings AL Bindman J Phillips J Bergmann K (1992) Combination treatment with noradrenalin and serotonin reuptake inhibitors in resistant depression. Br J Psychiatry 161: 562-565.
24. Shrivastava RK Cohn C Crowder J Davidson J Dunner D Feighner J (1994) Long-term safety and clinical acceptability of venlafaxine and imipramine in outpatients with major depression. J Clin Psychopharmacol 14: 322-329. (Pubitemid 24316929)
25. Smeraldi E Rizzo F Crespi G (1998) Double-blind, randomized study of venlafaxine, clomipramine and trazodone in geriatric patients with major depression. Primary Care Psychiatry 4: 189-195.
26. Smith D Dempster C Glanville J Freemantle N Anderson I (2002) Efficacy and tolerability of venlafaxine compared with selective serotonin reuptake inhibitors and other antidepressants: a meta-analysis. Br J Psychiatry 180: 396-404.
27. Stahl, SM Depression and bipolar disorder. In: SM Stahl (ed), Essential Psychopharmacology. Cambridge: Cambridge University Press.
28. Stahl SM Entsuah R Rudolph RL (2002) Comparative efficacy between venlafaxine and SSRIs: a pooled analysis of patients with depression. Biol Psychiatry 52: 1166-1174.
29. Stewart LA Parmar MK (1996) Bias in the analysis and reporting of randomized controlled trials. Int J Technol Assess Health Care 12: 264-275.
30. Thase ME Entsuah AR Rudolph RL (2001) Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors. Br J Psychiatry 178: 234-241.
31. Thase ME Shelton RC Khan A (2006) Treatment with venlafaxine extended release after SSRI nonresponse or intolerance. J Clin Psychopharmacol 26: 250-258.
32. Tiihonen J Lnnqvist J Wahlbeck K Klaukka T Tanskanen A Haukka J (2006) Antidepressants and the risk of suicide, attempted suicide, and overall mortality in a nationwide cohort. Arch Gen Psychiatry 63: 1358-1367.
33. van den Broek WW Birkenhager TK Mulder PG Bruijn JA Moleman P (2004) A double-blind randomized study comparing imipramine with fluvoxamine in depressed inpatients. Psychopharmacology (Berl) 175: 481-486.
34. Whyte EM Basinski J Farhi P Dew MA Begley A Mulsant BH (2004) Geriatric depression treatment in nonresponders to selective serotonin reuptake inhibitors. J Clin Psychiatry 65: 1634-1641.